First quarter report Q1-2021 - ‘one down, two to go’ of the major milestones of 2021
Cessatech A/S (“Cessatech” or the “Company”) today releases its results for the period 1 January – 31 March 2021. The report is available as an attached document to this press release and on www.cessatech.com under Investor, ‘Filings & Reports’. The company is on track with Q1 activities, has initiated the bioavailability trial 0204 and was awarded best medical IPO in 2020 in the Nordics.First quarter 2021 (1 January – 31 March): · Net revenue was KDKK 0 · Operating result was KDKK -2,863 · Net result was KDKK -2,458 · Cash at bank was KDKK 11,148 · Earnings per share*